Author Correction:Discovery of a selective TRF2 inhibitor FKB04 induced telomere shortening and senescence in liver cancer cells  

作　　者：Yin-da Qiu Qi Yan Yi Wang Yan-fei Ye Yan Wang Meng-ying Wang Pei-pei Wang Shu-yuan Zhang Da-long Wang Hao Yan Jing Ruan Yun-jie Zhao Le-hao Huang Namki Cho Kun Wang Xiao-hui Zheng Zhi-guo Liu 

机构地区：[1]School of Pharmaceutical Science,Wenzhou Medical University,Wenzhou,325035,China [2]College of Pharmacy,Chonnam National University,Gwangju,61186,Republic of Korea [3]Department of Pathology,The First Affiliated Hospital of Wenzhou Medical University,Wenzhou,325035,China [4]Oujiang Laboratory,School of Pharmaceutical Science,Wenzhou Medical University,Wenzhou,325035,China

出　　处：《Acta Pharmacologica Sinica》2025年第2期512-514,共3页中国药理学报(英文版)

摘　　要：Correction to:Acta Pharmacologica Sinica(2024)45:1276-1286 https://doi.org/10.1038/s41401-024-01243-6;Article published online 4 March 2024 Substituents of active compounds FKB04 are incorrectly plotted in Figure 2a and supporting information.The correct version including the structure and scheme of FKB04 is shown.The corrigendum does not affect the interpretation of data and conclusions,The authors deeply feel sorry and apologize for all the inconvenience this may have caused.

关 键 词：FIGURE SHORTENING supporting 

分 类 号：R73[医药卫生—肿瘤]